• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞特异性适体作为治疗应用中的潜在药物:当前进展综述。

Cell-specific aptamers as potential drugs in therapeutic applications: A review of current progress.

机构信息

Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100083, China; College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.

Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100083, China.

出版信息

J Control Release. 2022 Jun;346:405-420. doi: 10.1016/j.jconrel.2022.04.039. Epub 2022 May 4.

DOI:10.1016/j.jconrel.2022.04.039
PMID:35489545
Abstract

Cell-specific aptamers are a promising emerging player in the field of disease therapy. This paper reviews the multidimensional research progress made in terms of their classification, modification, and application. Based on the target location of cell-specific aptamers, it is defined and classified cell-specific aptamers into three groups including aptamers for cell surface markers, aptamers for intracellular components, and aptamers for extracellular components. Moreover, the modification methods of aptamers to achieve improved stability and affinity are concluded. In addition, recent advances in the application of cell-specific aptamers are discussed, mainly focusing on the increasing research attraction of cell state improving helpers and cell recruitment mediators in the improvement of cellular microenvironments to achieve successful disease therapy. This review also highlights 11 types of clinical aptamer drugs. Finally, the challenges and future directions of potential clinical applications are presented. In summary, we believe that cell-specific aptamers are promising drugs in disease therapy.

摘要

细胞特异性适体是疾病治疗领域中一种有前途的新兴药物。本文综述了其分类、修饰和应用方面的多维研究进展。根据细胞特异性适体的靶位位置,将其定义并分类为细胞表面标志物适体、细胞内成分适体和细胞外成分适体三类。此外,还总结了适体的修饰方法,以提高其稳定性和亲和力。此外,还讨论了细胞特异性适体的最新应用进展,主要集中在细胞状态改善辅助物和细胞募集介质在改善细胞微环境方面的研究吸引力不断增加,以实现成功的疾病治疗。本文还重点介绍了 11 种临床适体药物。最后提出了潜在临床应用的挑战和未来方向。总之,我们相信细胞特异性适体是疾病治疗中有前途的药物。

相似文献

1
Cell-specific aptamers as potential drugs in therapeutic applications: A review of current progress.细胞特异性适体作为治疗应用中的潜在药物:当前进展综述。
J Control Release. 2022 Jun;346:405-420. doi: 10.1016/j.jconrel.2022.04.039. Epub 2022 May 4.
2
Aptamers: multifunctional molecules for biomedical research.适配体:用于生物医学研究的多功能分子。
J Mol Med (Berl). 2013 Dec;91(12):1333-42. doi: 10.1007/s00109-013-1085-2. Epub 2013 Sep 18.
3
Aptamer applications for targeted cancer therapy.适体在肿瘤靶向治疗中的应用。
Future Oncol. 2010 Jul;6(7):1117-26. doi: 10.2217/fon.10.67.
4
The development and testing of aptamers for cancer.用于癌症的适配体的开发与测试。
Curr Opin Investig Drugs. 2009 Jun;10(6):572-8.
5
Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.寡核苷酸适体:筛选、分子构象和治疗应用的最新进展。
Biomed Pharmacother. 2021 Nov;143:112232. doi: 10.1016/j.biopha.2021.112232. Epub 2021 Sep 25.
6
Therapeutic applications of DNA and RNA aptamers.DNA和RNA适配体的治疗应用。
Oligonucleotides. 2009 Sep;19(3):209-22. doi: 10.1089/oli.2009.0199.
7
Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.治疗性寡核苷酸适配体的分子筛选、修饰与开发
Int J Mol Sci. 2016 Mar 11;17(3):358. doi: 10.3390/ijms17030358.
8
Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.智能配体:适体介导的化疗药物和 siRNA 的靶向递药用于癌症治疗。
J Control Release. 2013 Oct 28;171(2):152-62. doi: 10.1016/j.jconrel.2013.06.006. Epub 2013 Jun 15.
9
Aptamer-functionalized liposomes for drug delivery.适配子功能化脂质体用于药物递送。
Biomed J. 2024 Aug;47(4):100685. doi: 10.1016/j.bj.2023.100685. Epub 2023 Dec 10.
10
Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.通过细胞指数富集配体系统进化技术筛选的适体在筛选过程、癌症诊断与治疗中的进展。
Anal Biochem. 2020 Jun 1;598:113620. doi: 10.1016/j.ab.2020.113620. Epub 2020 Feb 19.

引用本文的文献

1
Using RNA therapeutics to promote healthy aging.利用RNA疗法促进健康衰老。
Nat Aging. 2025 Jun;5(6):968-983. doi: 10.1038/s43587-025-00895-1. Epub 2025 Jun 11.
2
Advancing the potential of nanoparticles for cancer detection and precision therapeutics.提升纳米颗粒在癌症检测和精准治疗方面的潜力。
Med Oncol. 2025 Jun 4;42(7):239. doi: 10.1007/s12032-025-02782-6.
3
Aptamer and Oligonucleotide-Based Biosensors for Health Applications.用于健康应用的适配体和基于寡核苷酸的生物传感器。
Biosensors (Basel). 2025 Apr 29;15(5):277. doi: 10.3390/bios15050277.
4
Golden insights for exploring cancer: delivery, from genes to the human body using bimetallic Au/Ag nanostructures.探索癌症的宝贵见解:利用双金属金/银纳米结构从基因到人体的传递
Discov Oncol. 2025 May 25;16(1):918. doi: 10.1007/s12672-025-02714-w.
5
Sorting high-affinity aptamers in a single selection round.在单次筛选轮次中筛选高亲和力适配体。
Nat Chem Biol. 2025 May 22. doi: 10.1038/s41589-025-01917-0.
6
Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management.利用RNA疗法:心血管疾病管理的新方法和新兴策略
Front Cardiovasc Med. 2025 Mar 20;12:1546515. doi: 10.3389/fcvm.2025.1546515. eCollection 2025.
7
Emerging Biohybrids of Aptamer-Based Nano-Biosensing Technologies for Effective Early Cancer Detection.基于适体的纳米生物传感技术的新兴生物杂交体用于有效的早期癌症检测。
Mol Diagn Ther. 2024 Jul;28(4):425-453. doi: 10.1007/s40291-024-00717-x. Epub 2024 May 22.
8
Aptamer-functionalized hydrogels promote bone healing by selectively recruiting endogenous bone marrow mesenchymal stem cells.适配体功能化水凝胶通过选择性募集内源性骨髓间充质干细胞促进骨愈合。
Mater Today Bio. 2023 Nov 7;23:100854. doi: 10.1016/j.mtbio.2023.100854. eCollection 2023 Dec.
9
Supramolecular Nucleic Acid-Based Organosilica Nanoparticles Responsive to Physical and Biological Inputs.基于超分子核酸的有机硅纳米粒子,对物理和生物输入有响应。
J Am Chem Soc. 2023 Oct 25;145(42):22903-22912. doi: 10.1021/jacs.3c04345. Epub 2023 Oct 16.
10
Updated Considerations for the Immunopharmacological Aspects of the "Talented mRNA Vaccines".“卓越信使核糖核酸疫苗”免疫药理学方面的最新考量
Vaccines (Basel). 2023 Sep 12;11(9):1481. doi: 10.3390/vaccines11091481.